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Background: Insulin-resistant cardiomyocytes are characterized by a
decreased ability of insulin to stimulate glucose uptake. We have previously
shown that the activation of AMPK by metformin or phenformin restores
insulin-sensitivity in insulin-resistant cardiomyocytes. The aim of our present
work is to understand by which molecular mechanisms AMPK exerts its
insulin sensitizing effect. In this study we focused on the mTOR/p70S6K
pathway and on cytoskeleton reorganization. mTOR/p70S6K, which is known
to be inhibited by AMPK, is able to reduce insulin signaling via a negative
feedback loop involving serine phosphorylation of IRS-1. On the other hand,
cytoskeleton reorganization, which is a known target of AMPK, is responsible
for the translocation of the glucose transporter GLUT4 to the plasma mem-
brane.
Methods: Adult rat cardiomyocytes were primary cultured and treated
with different agents including insulin, AMPK activator (phenformin), mTOR
inhibitor rapamycin and/or actin cytoskeleton inhibitor latrunculin B. Glucose
uptake was assessed by detritiation of 2-3H-glucose.
Results: First, we tested if rapamycin was able to mimic AMPK activators.
Similarly to phenformin, rapamycin increased the insulin-dependent phosphor-
ylation of Akt involved in the regulation of glucose uptake. Despite the ability
of rapamycin to induce this Akt over-phosphorylation, rapamycin was not able
to restore the insulin-dependent stimulation of glucose uptake like phenformin
did. On the other hand, latrunculin B abolished the insulin-sensitizing action
of phenformin on glucose uptake, in insulin-sensitive as well as in insulin-
resistant cells.
Conclusions: actin cytoskeleton reorganization but not mTOR/p70S6K, is
involved in the insulin-sensitizing effect of AMPK on cardiac glucose uptake.
The role played by Small G proteins, known to be involved in the regulation
of actin cytoskeleton is under investigation.
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A role for focal adhesion kinase in the stimulation of glucose transport
in cardiomyocytes
Christophe Montessuit
Université de Genève, FRM Cardiologie, Genève, Suisse
Background: Stimulation of glucose transport in response to insulin or
metabolic stress is an important determinant of cardiomyocytes function and
survival, particularly during ischemia-reperfusion episodes. Stimulation of
glucose transport is markedly impaired in cardiomyocytes exposed to free
fatty acids (FA), despite relative preservation of insulin- or metabolic stress
signaling.
Aim: To determine whether Focal Adhesion Kinase (FAK) activity is
required for stimulation of glucose transport in cardiomyocytes, and whether
FAK downregulation participates in FA-induced impairment of glucose trans-
port stimulation.
Methods: Glucose transport, measured in isolated cardiomyocytes, was
acutely stimulated either by insulin treatment, or by metabolic inhibition with
oligomycin resulting in AMP-activated kinase (AMPK) activation. FAK
activity was inhibited pharmacologically by preincubation with PF-573,228
(PF). FAK activity was assessed from its autophosphorylation on residue
Y397, and from the phosphorylation of paxillin on Y118.
Results: Y397 FAK phosphorylation was reduced in cardiomyocytes
chronically exposed to FA. Preincubation with PF prior to determination of
glucose transport resulted in a significant reduction of oligomycin-stimulated
glucose transport, with a modest reduction in insulin-stimulated glucose trans-
port. Insulin and AMPK signaling was unaffected by PF preincubation.
Intriguingly metabolic stress provoked Y397 FAK dephosphorylation and
deactivation, as evidenced by a concomitant reduction in Y118 paxillin phos-
phorylation.
Conclusions: stimulation of glucose transport by insulin or metabolic
stress in cardiomyocytes requires FAK activity prior to stimulation; FAK
activity is however acutely reduced during metabolic stress. The chronic
reduction of FAK activity in cardiomyocytes exposed to FFA partially
explains the loss of glucose transport responsiveness to insulin or metabolic
inhibition.
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Purpose: Studies have shown that aldosterone would have angiogenic
effects, and therefore would be beneficial in the context of cardiovascular dis-
eases. We thus investigated the potential involvement of aldosterone in trig-
gering a cardiac angiogenic response in the context of type-2 diabetes, and the
molecular pathways involved.
Procedure: 3 week-old male mice, overexpressing aldosterone-synthase
(AS), and their controls littermates (WT) were fed with a standard or high fat,
high sucrose (HFHS) diet. After 6 months of diet, mice were sacrificed and
cardiac samples were assayed by RT-PCR, immuno-blotting and -histology.
Findings: HFHS-diet induced type-2 diabetes (D) in WT and AS mice.
VEGFa mRNAs were decreased in WT-D (–43%, P<0.05 vs. WT) while
increased in AS-D mice (+236%, P<0.01 vs. WT-D). In WT-D hearts, the pro-
apoptotic p38-MAPK was activated (P<0.05 vs. WT and AS-D) whereas Akt
activity decreased. The AS-mice, that exhibited a cardiac upregulation of
IGF1-R, showed an increase in Akt phosphorylation when diabetic (P<0.05
vs. WT and AS-D). Contrary to WT-D, AS-D hearts did not express inflam-
matory markers and exhibited a normal capillary density (P<0.05 vs. WT-D)
Conclusions: To our knowledge, this is the first study providing new
insights into the mechanisms whereby aldosterone prevents diabetes-induced
cardiac disorders.
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The obesity-related cardiomyopathy is a poorly explained disease. There is
no data available on myofilaments sensitivity to calcium and post-transla-
tionnal modification or isoform shifts of sarcomeric proteins that could be
involved in the contractile impairment. We conducted a study on obese and
non obese human atrial trabeculae of the right atrium collected in the surgery
room during cardiopulmonary bypass. We studied the contractile force of the
trabeculae, the sensitivity of the myofilaments to Ca2+. Western blots were
performed in order to explore the post-translationnal modification of sarco-
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